Potency assays in cell therapies: A look behind the challenges
Potency assays are a cornerstone of effective cell therapies, but they can also be a source of delay during development. We spoke with Scott Jones, PhD, Senior Vice President and Chief Scientific Officer at BioBridge Global (BBG) to understand the challenges of product-specific potency assays and the solutions for streamlined success.
